ZifamProducts

Find Product

Categories

Zisuva 625mg/1G

  • ENG
  • မြန်မာ

COMPOSITION

ZISUVA 625mg

Each uncoated tablet contains:

Amoxicillin Trihydrate BP equivalent to Amoxicillin …………………………… 500mg
Potassium Clavulanate BP equivalent to (as Diluted Potassium Clavulanate BP) Clavulanic acid…….. 125mg
Excipients ………………………………….. q.s.

 

ZISUVA 1G

Each uncoated tablet contains:

Amoxicillin Trihydrate BP equivalent to Amoxicillin …………………………… 875mg
Potassium Clavulanate BP equivalent to (as Diluted Potassium Clavulanate BP) Clavulanic acid…….. 125mg
Excipients ………………………………….. q.s.

 

INDICATIONS

Treatment of otitis media, sinusitis, and infections caused by susceptible organisms involving the lower respiratory tract, skin and skin structure, and urinary tract; spectrum same as amoxicillin with additional coverage of beta-lactamase producing B. catarrhalis, H. influenzae, N. gonorrhoeae, and S. aureus (not MRSA). The expanded coverage of this combination makes it a useful alternative when amoxicillin resistance is present and patients cannot tolerate alternative treatments.

 

DOSAGE AND ADMINISTRATION

Adults and children > 40 kg:

Recommended dose:
Mild to moderate infection – 500mg/125mg two to three times a day according to types of infection.

Severe infection – 500mg/125mg three times a day or 875mg/125mg two times a day.

 
Children < 40 kg
20mg/5 mg/kg/day to 60 mg/15mg/kg/day given in three divided doses.

 

SIDE-EFFECTS AND SPECIAL PRECAUTIONS

Amoxicillin and Potassium Clavulanate is generally well tolerated. The majority of side effects observed in clinical trials were of a mild and transient nature and less than 3% of patients discontinued therapy because of drug-related side effects.The most frequently reported adverse effects were diarrhea?loose stools (9%), nausea (3%), skin rashes and urticaria (3%), vomiting (1%) and vaginitis (1%). The overall incidence of side effects, and in particular diarrhea, increased with the higher recommended dose.Other less frequently reported reactions include:Abdominal discomfort, flatulence and headache.
Gastrointestinal: Diarrhea, nausea, vomiting, indigestion, gastritis, stomatitis, glossitis, black “hairy” tongue, mucocutaneous candidiasis, enterocolitis, and hemorrhagic/pseudomembranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment.
 

STORAGE

Store below 25’C. Protect from light and moisture.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
 

PRESENTATION

Zisuva 625mg – Carton contains 2 blister strips of 7 tablets
Zisuva 1G – Carton contains 1 blister strips of 10 tablets

 

Manufactured by:

Zifam Pyrex Myanmar Co., Ltd.

Lot C6, Zone-A, Thilawa SEZ, Thanlyin and Kyaut Tan Township, Yangon, Myanmar. 

 

Product of

Zifam Pinnacle Pty.Ltd

The Healthcare Group


Related Products